Prevalence of Diabetes Mellitus Comorbidity in COVID-19 Patients Treated at Selected Hospital in Surabaya

Nurida Alfi Mustafida¹ , Diyantoro ² , Aliyah Siti Sundari³ , Dwi Wahyu Indriati⁴

Section:Research Paper, Product Type: Journal-Paper
Vol.9 , Issue.1 , pp.32-34, Feb-2022

Online published on Feb 28, 2022

Copyright © Nurida Alfi Mustafida, Diyantoro, Aliyah Siti Sundari, Dwi Wahyu Indriati . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

Abstract :
COVID-19 or commonly called Coronavirus disease 2019 by the World Health Organization (WHO) is a new virus that is currently troubling people in all parts of the world and having a very significant impact on human life, especially in the health sector. COVID-19 is an infectious disease caused by the acute respiratory syndrome coronavirus. Diabetes Mellitus (DM) is one of the risk factors for increasing the severity of COVID-19 infection. Older patients (>60 years), uncontrolled blood sugar levels, and the presence of diabetic complications are associated with a poorer COVID-19 prognosis. This study aims to determine the prevalence of comorbid diabetes mellitus in COVID-19 positive patients at selected hospital in Surabaya in 2020. This study used the Observational Analytic Cross-sectional method using secondary data from records of blood sugar examination results in the clinical pathology laboratory at at selected hospital in Surabaya in 2020. Data in the form of positive COVID-19 patients who were confirmed with PCR test results in 2020. The results of the study obtained data as many as 151 positive COVID-19 patients who underwent blood sugar checks, with a history of diabetes mellitus as much as 29.9% and the majority group aged 56-65 years, namely as much as 42.2% can be seen from the gender where women are more vulnerable that is equal to 64.4%. Both COVID-19 patients and DM patients are expected to better manage themselves to avoid complications.

Key-Words / Index Term :
Component, Formatting, Style, Styling, Insert

References :
[1] J. Yang, Y. Zheng, X. Gou, K. Pu, Z. Chen, Q. Guo, R. Ji, H. Wang, Y. Wang, Y. Zhou, “Prevalence of Comorbidities in the Novel Wuhan Coronavirus (COVID-19) Infection: A Systematic Review and Meta-analysis,” International Journal of Infectious Disease, Vol.94, Issue.2020, pp.91-95, 2020.
[2] Z. Wu, J.M. McGoogan, “Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72.314 Cases from the Chinese Center for Disease Control and Prevention,” Journal of the American Medical Association, Vol.323, Issue.13, pp.1239-1242, 2020.
[3] American Diabetes Association, “Standards of Medical Care in Diabetes-2017 Abridged for Primary Care Providers,” Clinical diabetes: a publication of the American Diabetes Association, Vol.35, Issue.1, pp.1-5, 2017.
[4] L. Guariguata, D.R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, J.E. Shaw, “Global Estimates of Diabetes Prevalence for 2013 and Projections for 2035,” Diabetes Research and Clinical Practice, Vol.103, Issue.2, pp.137-149, 2014.
[5] World Health Organization, “Global Report on Diabetes. WHO Library Cataloguing-in-Publication Data Global, 2016. In W.P. Sudarmaji, N. Nursalam, S. Wulandari, “Identification of Nursing Problems in Hospitalized Patients with Diabetes Mellitus,” Jurnal Ners, Vol.15, Issue.2, pp.480-485, 2020.
[6] G. Onder, G. Rezza, S. Brusaferro, “Case-fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy” Jama, Vol.323, Issue.18, pp.1775-1776, 2020.
[7] J.M. Caldwell, E. de Lara-Tuprio, T.R. Teng, M.R.J.E. Estuar, R.F.R. Sarmiento, M. Abayawardana, R.N.F. Leong, R.T. Gray, J.G. Wood, L. Le, E.S. McBryde, R. Ragonnet, J.M. Trauer, “Understanding COVID-19 Dynamics and the Effects of Interventions in the Philippines: A Mathematical Modelling Study,” The Lancet Regional Health – Western Pacific, Vol.14, Issue.2021, pp.100211, 2021.
[8] J. Casqueiro, J. Casqueiro, C. Alves C, “Infections in Patients with Diabetes Mellitus: A Review of Pathogenesis,” Indian Journal of Endocrinology and Metabolism, Vol.16, Issue.Suppl1, pp.27-36, 2012.
[9] C. Cristelo, C. Azevedo, J.M. Marques, R. Nunes, B. Sarmento, “SARS-CoV-2 and Diabetes: New Challenges for the Disease,” Diabetes Research and Clinical Practice, Vol.164, Issue.2020, pp.108228, 2020.
[10] S. Shah, P. Sonawane, P. Nahar, S. Vaidya, S. Salvi, “Pulmonary Function Tests in Type 2 Diabetes Mellitus and Their Association with Glycemic Control and Duration of the Disease,” Lung India, Vol.30, Issue.2, pp.108-112, 2013.
[11] S.K. Trisnawati, S. Setyorogo, “Risk Factors for Type II Diabetes Mellitus at Cengkareng Sub-District Health Center, West Jakarta in 2012,” Jurnal Ilmiah Kesehatan, Vol.5, Issue.1, pp.6-11, 2013.
[12] Zahtamal, F. Chandra, Suyanto, T. Restuastuti, “Risk Factors for Diabetes Mellitus Petients,” Berita Kedokteran Masyarakat, Vol.23, Issue.3, pp.142-147, 2007.
[13] S. Imelda, “Factors Affecting the Occurrence of Diabetes Mellitus at Harapan Raya Health Center in 2018,” Scientia Journal, Vol.8, Issue.1, pp.28-39, 2019.
[14] W. Wang, J. Lu, W. Gu, Y. Zhang, J. Liu, G. Ning, “Care for Diabetes with COVID-19: Advice from China,” Journal of Diabetes, Vol.12, Issue.5, pp.417-419, 2020.